Existing vaccines for the protection of labora-preparations to confer protection in animals was tory personnel potenittilly exposed to Venezuelan investigated, and the results are presented in this equine encephalitis (VEE) -Arus include several report. Formalin-inactivated preparations (8, 10; Smith et al., Bacteriol Proc., p. 59, 1954.) and a live, MATERI.LS AN METHODS attenuated vaccine (2). Unfortunately, the Virus. The Trinidad -train of VEE virus, onginal;y Formalin-treated VEE vaccines either contain isolated in guinea pigs from a donkey brain (9), was residual infectious virus (15) or are so drastically used. It had been passaged 13 times in chicken emtreated as to confer inadeqtate protection (2, 7)_ bros when it s obtained through the courtesy of our colleague William P. Allen. Working seeds for The five, attenuated vaccine, although conferring teesuiswr rordfo eodscln these studies were prepared from a second suckling good protection in man (7), causes a significant mouse brain passage as I0 suspensions of infected incidence of undesirable clinical manifestations suckling mouse brains in 7.5% bovine serum albumin-(1). An experimental tissue culture vaccine inac-borate saline. " tivated by ionizing radiation was recently deInfectivity and amigenicity determinations. Assays scribed (13).
for virus infectivity were perfornum by plaque titration In studies to develop a more effective non-in 24-hr chick embryo monola.v; tissue cultures viable VEE vaccine, we have in,:estigated the (CE C) and by titration of lethality in -10-to 12-g applicability of two approaches not previously weanling mice. Sampies of irradiated virus that failed to produce plaques in tissue culture and were nonutilized in conjunction: purification and concertt pou pein mise ate nd i erebnonlethal for %veaning mice after joint intracerebr,31-tration of virus by diethylaminoethyl (DEAE) intraleritoneal inoculation (0.03 and 0.1 ml) were cellulose chromatography and inactivatirn by titrated in suckling mice for residual live virus by a ionizing radiation. The procedure proved ap-combination intracerebral and intraperitoneal inocuplicable to obtaining purified and inactivated lation of 0.02 and 0.03 ml, respectively (12). Fifty per VEE virus preparations that retained significant cent lethal dose end points (LDs*) were calculated by in vitro serological reactivity (4). The capability the method of Reed and Muench (1). Assays for viral of these serologically active noninfectious irus hemagglutinins (HA) and complement-fixing (CF) antigens were performed using microtiter methods I Present address: Viral Biolog, Branch. National Cancer (3, 14) . Goose erthrocytes, at pH 5.8, wvere used in HA Institutc National Institutes of Health, uethesU. Md. 20014. tests, and the Center for Disease Control Laboratory Braitch Complement Fixation (LBCF) procedure was exposure to 6 x 101 ganima radiation without employed in CF tests (16:. significant loss of in vitro antigenicity (4). This Tissue cultur. VEE virus w as grown in 24-hr chick method and dose of radiation were used to inacembryo monolayr tissue culture in a medium colsisttivate the vaccines used in this investigation. ing of 0.5% lactalbumin hydrolysate, 0.1% Ya The inactivation of virus preparations typically extract, !05)j% calf serum, and 0.14% sodium bicarbonate in Hanks balanced salt solution. Infected super-obtaird is indicated in Table 1 . As reported natant fluids were harvested by aspiration at IS to _V prevously, inactiv-ation of infectivity was linear hr postinfection. and tissue culture celluhlr debris was and complete at 6 X 10f: in contrast, both HA removed by slow-speed centrifugation. Prior to chro-and CF in vitro antigenicities were usually fully matography the clarified virus preparvtions were retained. dialyzed for I8 hr at 5 C against 10 volumes of water All the waccines examined were prepared from to decrease their salt concentration. This procedure chromatographed virus preparations of similar did not materially decrease VEE plaque titer or th. c levels. Inactivation, safety, sterility. Previous reports & All vaccines exposed to 6 X 10'.
from this laboratory demonstrated that chromatInfectivity for tissue culture or lethility for ographically purified VEE virus is inactivated by weanling and suckling mice. volume was used for these %afety tests. None of conducted with additional saline (IIFS) and the vaccines produced plaques in tissue culture histidine (IIFJ-) fluid vaccines derived from an after inoculation with Il-to 10-2 Ciluted ma-independent tissue culture harvest, column teral. Both 21 -day wea;!iing mce and I-to 5.day purification, and inactivation. The groups of mice, suckling mice survived inoculation witl. 107 to the dilutions of vaccines, and the number of 10-2 diluted vaccines, With th.! later vaccines, immunizipg injections used were as noted abovethe weanhing and suckling mice received intra-In this study, however, a 0.3-mi viume of va2c-cerebral-intraperitoneal injections. None of the cine was used for immunization, Protection was surviving mice showed any signs of specific ill-assayed by intraperitoneal inoc-alaton of 100,000 ness. and all Panials were observed for at least MIPLOA of Trinidad strain N EE vrirus 21 days 14 days. With the last vaccine, guinea pigs were after the Last injection-The re;ults are presented employed as z test animal. and no deaths resulted in Table 4 . Despite the higher challenge dose from inoculation of undfiluted irradiated ma-used. the high levei of protection observed with terial. No residual live virus was detected by any the previous vaccinies w-as afgain obtained. Mice ofithe tesv employed, receiving three injec-tions of either -vaccine diluted The iriadiated vaccines wmere tested for the pres-1:100 were completely proeted. Mice injected ence of bacteria by inoculation of fluid thioglycol-once wvith undiluted vaccire were similarly prolate broth and Brain Heart Infuson agar media. tected. A dose response relationship wa; again Incubation was perforrmed at both 37 C and at roomn temperature (22 -O.
-r,,.
1-nre
or 0.5% histidine (117H) were tested for their Intraperitonezi challenge with 5,000.%IlPi.Dso of Trinidad strain VEE virus 21 days after the of Trinidad strain VEE virus. None of 10 nonlast immunizing injection. Nonimmunized con-immunized control mice survived simultaneous trol mice of the same age and sex were chal-challenge. .enged simultaneously, and similar mice were also used to titrate the challenge suspension. The TAt;LE 4-Effect of VEE fluid raccine concent ration results are presented in In a more extensive study, two groups of 2 failed to survive simultaneous challenge. adult (18 to 20 g) mice wx-re immumized via the ion of guinea pigs. To detrmine subcutaneous route with ither oar. or two in-further the protection conferred by these adjections of vaccine combined with adjuvant juvant-combind nonviable VEE vaccines. in-(IIAH). As before, the ombination v acine munogenicity studies were extended to include consisted of an emulsion of equal parts of fluid the guinea pig. This species was selected because (histidine) vaccine and adjuvant 65. The fluid it made availble for further serological and va mccine used in this study was the fourth vaccine pathological studies a 10-fold larger ,mninal and derived from an independent tissue culture also because of the guinea pig's marked semiharvest, column purificatior,, and inactivation. tivity to lethal VEE virus infiection. Two groups -The olume of combined vaccine injected was of 15 young adult guinea pigs (250 to 300 gi 0.5 ml, and the multiple injections were 28 days were immunized 1 w one or two subcutaneous inoculations of 0.5 ml of a new adjuvrant-comapart. Immunizations were spaced so that both ineduvacine ofI0. Th flirus portiono grous ofmite er chalengl smultneoulybined vaccine (IIIAH). Thefluid-virus portion of groups of mice %we challenged simultaneously. Preection was assayed by intrapeitoneal injec-this vaccine represented the fifth independent tion of l(k3000 MIPLDA of Trinidad strain VEE growth, purification, and inactivation of VEE virus 21 days after the last immunizing injection, virus. Mtltiple injections were spaced 28 days Results are presented in Table 5 . The combina-apart, and immunizations were scheduled so that tion vaccine afforded the mice excellent protec-both groups of guinea pigs were challenged at tion. All 25 mice that received two immuniza-the same time. Immunogenicity was determined tions and 2-4 of the 25 mice that were inoculated by protection from a lethal intraperitoneal chub only onc. .iarvivt-d challenge. Furthermore. nor-lenge of 1,000.000 GPlPLD of Trinidad strain of the 49 surviving mice demonstrated any sigas VEE virus 21 days after the last Immunizing inof illness. In contrast, all nonimmunized contro! jection. Results are given in Table 6 . The combination vaccine completely protected the guinea antig n concentration and minimal nonimmuno= cine to protect half of th--icu. Two vacci ms that eenit. constituents is a common aim of those were partially puritkd by ultracentrifugation apst.Azying new approaches to viral immunization. parently required tw-,. (EDz of 0.01) and three !arlier reports from this laboratory indicated that (EDZ. of 0.017) imm,. nizazions of 1:2.5 dilution VEE virus preparations of high purity and con-of virus for best effect. Dur studies of diluted fluid centration were obtained by DAE cellulose vaccines in mice furnisi similar data from which chromatography and that ionizing radiation valid comparisons can x made. Mice inoculated destroyed the infectivity of such preparations twice with purifid .' VIE %accines (IIFS. IIFH) without significant damage to their in vitro (HA. and subjected to an e 4uivalnt lethal cha3lenue CF) antigenic activity. This present report indi- (Table 4) were comph tely proLcted with 1:10 cu ' s that these purified and inactivated prepara-diluted vaccine znd e'ihbited more than _0-tions are capable of stimulating a marked re-survival with --ccines dilutd 1:100 (this represpon " in host animals, resulting in in vivo pro-sents an ED-, of <00 .:0. dditionally. these tection against lethal challenge, and that they purifix-d vdccine pro.d-ed 50'" prozection to mice are thereLy of high immunogenic potency.
at 1:10 dilution Mith only one inoculation and Inactivated vaccines of high potency prepared 100f. protection to -Ad! mice when three immnu-ifrom viruses with unusual stability and resistance ations of I: PO diluted va-ccines were uszid. With to inactivation require exacting safety tests to guinc-pigs, direct -om.nparisons are not possible exclude the potential presence of residual live since we used an adiuvant-combin-d vaccine virus. In this study, three different criteria were administered via the sub cutaneous route. but it routinely used to measure virus inactivation: should 'e noted that the purified and adjurdntlack of plaque formation in CETC. lack of combind " aczire prote-ed i009-of guinea piy, lethality for ,eanling mice, and lack of lethality receiving only a single immunization. for very susceptible newborn mice. Additional The susceptibility of mice to peripheral inc luevidence of inactivation is available from the lation with most arbovirues. in contrast to vaccine studies themselves. The failure of im-intracerebral ia=,_ulation, usually diminishes munized weanling mice to die during the holding markedly with increasing age. This decr-maing period after an initial immunizing injection. :,usceptibility presents problems in vaccine studies where a substantial volume of undiluted and where mice are held to maturity before being diluted vaccine was employed, provides an even challenged. However, intraperitoneal neutralizamore sensitive indication of the absence of tion tests with VEE virus were shown to give resiatual live virus in the irradiated preparations-uniform results in mice of any age up to at least Further evidence of virus inactivation and an 200 days, and the quantity of virus neutralized additionl indication that immunogenic stimula-was 1,200 to .20000 times that neutralized by the tion by 'he vaccines is not due to subclinical intracerebral route (6. Thus, survival of adult infiectt. by_ trace amounts of residual live virus mice after lethal intraperitoneaml challene-is a are apparent in the results of the fluid vmccine valid test for evaluating immunity to VEE virus. studies in mice. Excellent protection of im Adjuvant 65 is a nontoxic and metabo!izable munteed animals was obtained with vaccines oil vehicle for aqueous vaccines. It has been most diluted as much as 1:100 after inactivation and thoroughly tested in its application to influenza safety testing of the preparations. To attribute virus vaccines and has proved highly effective in the protection observed to potential residual potentiating the level and duration of antibody ive virus would require an assumption that the both in animals and in man (5). It seemed d_-assay systems are not capable of detecting live sirable to determine the applicability of this virus in excess of 2 log.--This is obviously not adjuvant to the VEE virus vaccins under investithe case, and the immunogenicity observed is gation. The VEE virus-adjuvant-combined vacevidently a property of the inactivated virus.
cines in mice proved to be at least as ,ltS-civez as The immunogenic potency of the nonviable similar fluid vaccines. Weanling mice inoculated vaccines described in this report is similar to that intraperitoneally and adult mice inoculated subof other recently described VEE vaccines that cutaneously w-re both afforded essentially corn were also inactivated by ionizing radiation (13). plete protection with one inoculation of combined Those vaccines were evaluated by determination vaccine. Guinea pigs inoculated once and subp of the 50 effective dose (EDI,), the quantity of jected to an extremely high challenge dose were undiluted vaccine protecting 50-( of tested ani-similarly protected. No incompatibility with VEE mals from a lethal challenge. The most potent virus immunogens was noted, and no macrotissue culture vaccine of several described for mice scopic lesions or other pathology was observed iEDa of 0.0036) apparently required two im-at the inoculation sites. Further studies of the munizing inoculations of a 1:70 dilution of vac-immuno!ogical protection conferred by adjuvant
